Gene · 9002
Papers2,206
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,206
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Protease activated receptor-4: ready to be part of the antithrombosis spectrum. | Curr Opin Hematol | 2024 | 38814792 | PubTator, text mining | PubMed |
| F2RL3 Regulates Epithelial-Mesenchymal Transition and Angiogenesis in Gastric Cancer through the Rap1/MAPK Signaling Pathway. | Front Biosci (Landmark Ed) | 2024 | 38812308 | PubTator, text mining | PubMed |
| Elevated protease-activated receptor 4 (PAR4) gene expression in Alzheimer's disease predicts cognitive decline. | Neurobiol Aging | 2024 | 38761538 | PubTator, text mining | PubMed |
| Direct neuronal protection by the protease-activated receptor PAR4 antagonist ML354 after experimental stroke in mice. | Br J Pharmacol | 2024 | 38760890 | PubTator, text mining | PubMed |
| EnsemBic: An effective ensemble of biclustering to identify potential biomarkers of esophageal squamous cell carcinoma. | Comput Biol Chem | 2024 | 38759483 | PubTator, text mining | PubMed |
| PH-binding motifs as a platform for drug design: Lessons from protease-activated receptors; PARs. | Oncoscience | 2024 | 38699225 | PubTator, text mining | PubMed |
| MIF-Modulated Spinal Proteins Associated with Persistent Bladder Pain: A Proteomics Study. | Int J Mol Sci | 2024 | 38674069 | PubTator, text mining | PubMed |
| Ischemia does not provoke the full immune training repertoire in human cardiac fibroblasts. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 38652279 | PubTator, text mining | PubMed |
| The thrombin receptor PAR4 supports visceral adipose tissue inflammation. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 38652276 | PubTator, text mining | PubMed |
| Discovery of Protease-Activated Receptor 4 (PAR4)-Tethered Ligand Antagonists Using Ultralarge Virtual Screening. | ACS Pharmacol Transl Sci | 2024 | 38633591 | PubTator, text mining | PubMed |
| Discovery of 2,3-Dihydro[1,4]dioxino[2,3-g]benzofuran Derivatives as Protease Activated Receptor 4 (PAR4) Antagonists with Potent Antiplatelet Aggregation Activity and Low Bleeding Tendency. | J Med Chem | 2024 | 38552183 | PubTator, text mining | PubMed |
| A mouse model of the protease-activated receptor 4 Pro310Leu variant has reduced platelet reactivity. | J Thromb Haemost | 2024 | 38508397 | PubTator, text mining | PubMed |
| Eosinophils exhibit a unique transcriptional signature and increased sensitivity to IL-3-induced activation in response to colorectal cancer cells. | J Leukoc Biol | 2024 | 38478700 | PubTator, text mining | PubMed |
| House dust mite allergens induce Ca2+ signalling and alarmin responses in asthma airway epithelial cells. | Biochim Biophys Acta Mol Basis Dis | 2024 | 38367901 | PubTator, text mining | PubMed |
| Involvement of Protease-Activated Receptor2 Pleckstrin Homology Binding Domain in Ovarian Cancer: Expression in Fallopian Tubes and Drug Design. | Biomedicines | 2024 | 38275417 | PubTator, text mining | PubMed |
| Regulators of G-Protein Signaling (RGS) in Sporadic and Colitis-Associated Colorectal Cancer. | Int J Mol Sci | 2024 | 38203748 | PubTator, text mining | PubMed |
| Vitamin D3 improved hypoxia-induced lung injury by inhibiting the complement and coagulation cascade and autophagy pathway. | BMC Pulm Med | 2024 | 38166725 | PubTator, text mining | PubMed |
| Proteinase-activated Receptor 2: Springboard of Tumors. | Anticancer Res | 2024 | 38159988 | PubTator, text mining | PubMed |
| New insight into the agonism of protease-activated receptors as an immunotherapeutic strategy. | J Biol Chem | 2024 | 38159863 | PubTator, text mining | PubMed |
| The platelet storage lesion, what are we working for? | J Clin Lab Anal | 2024 | 38069592 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9002/papers?page=4